Transition from Intravenous Epoprostenol to Treprostinil Due to Intolerable Side Effects in Patients With Pulmonary Arterial Hypertension
- Resource Type
- Article
- Source
- In
The American Journal of Cardiology 1 November 2023 206:31-34 - Subject
- Language
- ISSN
- 0002-9149